AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
iTopia Epitope Discovery System launched for immune response prediction.
2004 JUL 7 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., (BEC) announced the commercial availability of its new iTopia Epitope Discovery System, which incorporates a proprietary technology announced last year at the World Vaccine Congress.
The new iTopia system provides biotechnology and pharmaceutical companies with a new tool for predicting immune response in vaccine characterization and design.
By mimicking in vivo peptide binding, an early indicator of immune response, the new system enables researchers to make better decisions earlier in the vaccine design and development process.
The system brings efficiency and specificity to vaccine design. iTopia can quickly identify the most immunogenic regions of the peptide/protein by employing well proven characterization techniques of on/off rates and affinity analysis to individual epitopes of the vaccine. The information obtained from the iTopia system can then be applied to the monitoring of patients in clinical trials by identifying the individuals a vaccine is most likely to protect.
...- Major Milestone Reached in Beckman Coulter's Cellular Immune Response...
- Press release article from: Business Wire November 21, 2002 700+ words
...and position Beckman Coulter as a leader in the immune response field...to evaluate immune response, and can...director of Beckman Coulter's Immunomics...of cellular immune response. Beckman Coulter, Inc. is...
- Major milestone reached in Beckman Coulter's cellular immune response...
- News wire article from: Asia Africa Intelligence Wire November 21, 2002 700+ words
...Press Release) Beckman Coulter Inc became the...s cellular immune response initiative...and position Beckman Coulter as a leader in the immune response field. Class...multiple sclerosis. Beckman Coulter Inc is a global...
- Beckman Coulter Introduces Tests to Measure Immune Response to Cytomegalovirus,...
- Press release article from: Business Wire July 24, 2001 700+ words
...July 24, 2001 Beckman Coulter, Inc. (NYSE...specific cellular immune response in these infectious...advancements in cellular immune response analysis of important...and director of Beckman Coulter's Immunomics...application of cellular immune response ...
- Beckman Coulter Introduces New Technology to Measure Cellular Immune Response;...
- Press release article from: Business Wire July 28, 2000 700+ words
...This cellular immune response technology...officer of Beckman Coulter. "In order...of cellular immune response." The company...of cellular immune response testing because...operations at Beckman Coulter. "As our...
- Beckman Coulter Introduces New Ready-to-Use MHC Tetramers to Measure Cellular...
- Press release article from: Business Wire January 16, 2001 700+ words
...study cellular immune response," stated...director of the Beckman Coulter Immunomics...detected an immune response in a patient...measurable immune response to the antigen...melanoma. Beckman Coulter's iTAg tetramers...
- Beckman Coulter Partners With THYMED to Develop Standardized Immune Monitoring...
- Press release article from: PR Newswire December 10, 2003 700+ words
...the agreement, Beckman Coulter has made an equity...the field of immune response testing. (Logo...platform includes Beckman Coulter's proprietary...in assessing immune response. "THYMED...vice president, Beckman Coulter's Translational...initiatives in ...
- Beckman Coulter Announces Commercial Availability of iTopia(TM) Epitope...
- Press release article from: PR Newswire June 8, 2004 700+ words
...Research Program Beckman Coulter, Inc., today...for predicting immune response in vaccine characterization...vice president of Beckman Coulter's Translational...position in the immune response field." Beckman Coulter has already signed...
- Beckman Coulter and Corixa Enter Technology Cross-License Agreement.
- Press release article from: Business Wire February 27, 2002 700+ words
...president and director of Beckman Coulter's Immunomics Operations. "Beckman Coulter is now in a position to accelerate our immune response programs to address...multiple sclerosis." Beckman Coulter is an exclusive licensee...
- Beckman Coulter announces new epitope discovery technology at 3rd Annual World...
- News wire article from: Asia Africa Intelligence Wire April 9, 2003 700+ words
...According to Raynor, Beckman Coulter's new epitope discovery...expertise in cellular immune response analysis, offers biopharmaceutical...are used in monitoring immune response. Based in Fullerton, CA, Beckman Coulter Inc is a global leader...
- Playing iTag, Redux: Beckman Coulter Immunomics releases MHC class II...
- Magazine article from: The Scientist Adams, Amy February 10, 2003 700+ words
...multiple sclerosis. Now Beckman Coulter Immunomics Operations...says, adding that Beckman Coulter Immunomics already...understand the overall immune response," she says. For...Reader Service #73 Beckman Coulter Immunomics (866...
Source: HighBeam Research, iTopia Epitope Discovery System launched for immune response...